How TRP channels affect diabetic nerve pain
Treatments studied
This study looks at how certain channels in your body (TRP channels) might be involved in diabetic peripheral neuropathy (nerve pain from diabetes), using tests on the skin. It may help find new ways to treat nerve pain.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a white man or woman between 18 and 45 years old
- You have not smoked for at least 6 months
- Your body mass index (BMI) is between 18 and 30
- You are in generally good health
- You can avoid caffeine for 24 hours before each study visit
- You can avoid alcohol for 24 hours before each study visit
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at “TRP channels,” which are part of how nerves sense pain and temperature, to understand nerve pain (neuropathy) after chemotherapy. It may help improve how future treatments prevent or reduce nerve pain in people who have had certain chemotherapy drugs.
This study tests how certain skin creams affect nerve channels in the skin. It may help find better ways to treat pain or sensitivity.
This study compares two approaches to treating nerve pain caused by diabetes. You may be eligible if your diabetic neuropathy is moderate to severe and you can reliably use a phone for study steps.
This study looks at how the nervous system becomes extra sensitive in people with diabetic nerve pain. It may help doctors understand why some people with diabetes feel pain and others don't, which could lead to better treatments.
This trial tests a new cream (Capsadyn®) made from chili pepper extract to see if it can reduce nerve pain in the feet caused by diabetes. If it works, it could offer a simple treatment you apply at home.
This trial tests a shortwave treatment to relieve pain and other nerve symptoms in people with diabetic peripheral neuropathy (nerve damage from diabetes). It is for adults who have not found enough relief from standard nerve medications.
Hear when a new Physiological Responses trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.